内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2020 ESE临床实践指南：肥胖的内分泌检查

2020-01-10 欧洲内分泌学会 Eur J Endocrinol. 2020 Jan;182(1):G1-G32.

肥胖内分泌检查

2020年1月，欧洲内分泌学会(ESE)发布了肥胖的内分泌检查指南，肥胖是一种很常见的病症，患病率大约20%。本文主要针对肥胖患者内分泌检查的相关内容提出指导建议。

中文标题：

2020 ESE临床实践指南：肥胖的内分泌检查

英文标题：

European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity.

发布机构：

欧洲内分泌学会

发布日期：

2020-01-10

简要介绍：

2020年1月，欧洲内分泌学会(ESE)发布了肥胖的内分泌检查指南，肥胖是一种很常见的病症，患病率大约20%。本文主要针对肥胖患者内分泌检查的相关内容提出指导建议。

 

拓展指南：与肥胖相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2020 ESE临床实践指南：肥胖的内分泌检查)] GetToolGuiderByIdResponse(projectId=1, id=986551c0018511d0, title=2020 ESE临床实践指南：肥胖的内分泌检查, enTitle=European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity., guiderFrom=Eur J Endocrinol. 2020 Jan;182(1):G1-G32., authorId=null, author=, summary=2020年1月，欧洲内分泌学会(ESE)发布了肥胖的内分泌检查指南，肥胖是一种很常见的病症，患病率大约20%。本文主要针对肥胖患者内分泌检查的相关内容提出指导建议。 , cover=, journalId=null, articlesId=null, associationId=916, associationName=欧洲内分泌学会, associationIntro=欧洲内分泌学会（The European Society of Endocrinology，ESE）是欧洲内分泌学者学习和交流的圣地，旨在通过组织会议、提供培训课程和出版物等方式，促进内分泌领域内公益性研究、教育和临床实践等项目，提高公众意识，并对相关法规的完善起到监督作用。ESE工作主要集中于以下方面：①举办欧洲内分泌会议（European Congress of Endocrinology，ECE），为业内人士交流最新成果和经验提供平台；②提供指南和政策，为临床医生和研究人员提供技术支持，如病人资料、培训课程等；③通过&ldquo;职业生涯&rdquo;栏目组建特别兴趣小组、欧洲青年内分泌科学家委员会、ESE护理小组等以便于会员之间交流合作等。ESE网站还有相关新闻、奖金、教育与科研、出版物以及媒体中心等栏目。, copyright=0, guiderPublishedTime=Fri Jan 10 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<P>2020年1月，欧洲内分泌学会(ESE)发布了肥胖的内分泌检查指南，肥胖是一种很常见的病症，患病率大约20%。本文主要针对肥胖患者内分泌检查的相关内容提出指导建议。 </P> <P> </P>拓展指南：<strong>与<font color=red>肥胖</font>相关指南：</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=b0d7d1c001e987f1" title="2019 年《欧洲实践指南：初级医疗中成年人肥胖的管理》解读" target=_blank>2019 年《欧洲实践指南：初级医疗中成年人肥胖的管理》解读</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=4aa991c001e795f9" title="2016 ISTH指南：使用直接口服抗凝剂治疗肥胖患者" target=_blank>2016 ISTH指南：使用直接口服抗凝剂治疗肥胖患者</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=f456f1c001e788f1" title="2019 BTS临床实践指南：肥胖低通气综合征的评估和管理" target=_blank>2019 BTS临床实践指南：肥胖低通气综合征的评估和管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=a58fb1c001e20217" title="2019 HFSA共识声明：心衰患者的营养，肥胖和恶病质" target=_blank>2019 HFSA共识声明：心衰患者的营养，肥胖和恶病质</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=dd8051c001696105" title="2019 欧洲实践指南：基层医疗中成人肥胖的管理" target=_blank>2019 欧洲实践指南：基层医疗中成人肥胖的管理</a></li> 更多信息请点击：<a href="https://www.medsci.cn/guideline/list.do?q=%E8%82%A5%E8%83%96" target=_blank>有关肥胖更多指南</a></ul>, tagList=[TagDto(tagId=332, tagName=肥胖), TagDto(tagId=98889, tagName=内分泌检查)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4812, appHits=258, showAppHits=0, pcHits=2274, showPcHits=3374, likes=59, shares=17, comments=6, approvalStatus=1, publishedTime=Fri Jan 17 23:52:24 CST 2020, publishedTimeString=2020-01-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Jan 17 23:52:24 CST 2020, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 22:39:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2020 ESE临床实践指南：肥胖的内分泌检查)])
2020 ESE临床实践指南：肥胖的内分泌检查
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1190992, encodeId=84d1119099220, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a075617739, createdName=云云玉玉, createdTime=Tue Feb 08 11:45:59 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954658, encodeId=268695465806, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:27:08 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913731, encodeId=a93d913e31b7, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/3c900244582a4b538413194c40975186/916293c2668b4bf8a437739fb14807e6.jpg, createdBy=4d295437825, createdName=努力努力再努力吧, createdTime=Mon Jan 04 22:03:19 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809850, encodeId=720b80985073, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d095409783, createdName=ms5000002046462755, createdTime=Mon Aug 17 21:05:13 CST 2020, time=2020-08-17, status=1, ipAttribution=)]
    2022-02-08 云云玉玉

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1190992, encodeId=84d1119099220, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a075617739, createdName=云云玉玉, createdTime=Tue Feb 08 11:45:59 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954658, encodeId=268695465806, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:27:08 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913731, encodeId=a93d913e31b7, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/3c900244582a4b538413194c40975186/916293c2668b4bf8a437739fb14807e6.jpg, createdBy=4d295437825, createdName=努力努力再努力吧, createdTime=Mon Jan 04 22:03:19 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809850, encodeId=720b80985073, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d095409783, createdName=ms5000002046462755, createdTime=Mon Aug 17 21:05:13 CST 2020, time=2020-08-17, status=1, ipAttribution=)]
    2021-04-07 ms6000001015893838

    资料好好，但无法分享，遗憾！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1190992, encodeId=84d1119099220, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a075617739, createdName=云云玉玉, createdTime=Tue Feb 08 11:45:59 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954658, encodeId=268695465806, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:27:08 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913731, encodeId=a93d913e31b7, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/3c900244582a4b538413194c40975186/916293c2668b4bf8a437739fb14807e6.jpg, createdBy=4d295437825, createdName=努力努力再努力吧, createdTime=Mon Jan 04 22:03:19 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809850, encodeId=720b80985073, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d095409783, createdName=ms5000002046462755, createdTime=Mon Aug 17 21:05:13 CST 2020, time=2020-08-17, status=1, ipAttribution=)]
    2021-01-04 努力努力再努力吧

    非常好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1190992, encodeId=84d1119099220, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a075617739, createdName=云云玉玉, createdTime=Tue Feb 08 11:45:59 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954658, encodeId=268695465806, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:27:08 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913731, encodeId=a93d913e31b7, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/3c900244582a4b538413194c40975186/916293c2668b4bf8a437739fb14807e6.jpg, createdBy=4d295437825, createdName=努力努力再努力吧, createdTime=Mon Jan 04 22:03:19 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809850, encodeId=720b80985073, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d095409783, createdName=ms5000002046462755, createdTime=Mon Aug 17 21:05:13 CST 2020, time=2020-08-17, status=1, ipAttribution=)]
    2020-08-17 ms5000002046462755

    好

    0

相关指南

2016 ISTH指南：使用直接口服抗凝剂治疗肥胖患者

国际血栓与止血学会(ISTH,International Society on Thrombosis and Haemostasis) · 2016-04-27

2019 HFSA共识声明：心衰患者的营养，肥胖和恶病质

美国心衰学会(HFSA,HEART FAILURE SOCIETY OF AMERICA) · 2019-03-12

2016年中国超重/肥胖医学营养治疗专家共识解读

暂未更新 · 2017-05-30

儿童肥胖筛查和治疗的承诺和机会：USPSTF建议声明 2017

美国预防医学工作组(USPSTF,U.S. Preventive Services Task Force) · 2017-06-24

2017 USPSTF建议声明：儿童和青少年肥胖筛查

美国预防医学工作组(USPSTF,U.S. Preventive Services Task Force) · 2017-06-20

非酒精性脂肪性肝病的治疗—欧洲肥胖-2型糖尿病-消化临床实践指南解读

暂未更新 · 2017-05-30